171 related articles for article (PubMed ID: 33404755)
1. Determination of plasma β-amyloids by rolling circle amplification chemiluminescent immunoassay for noninvasive diagnosis of Alzheimer's disease.
Wang D; Dai Y; Wang X; Yu P; Qu S; Liu Z; Cao Y; Zhang L; Ping Y; Liu W; Tao Z
Mikrochim Acta; 2021 Jan; 188(1):24. PubMed ID: 33404755
[TBL] [Abstract][Full Text] [Related]
2. A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease.
Shahpasand-Kroner H; Klafki HW; Bauer C; Schuchhardt J; Hüttenrauch M; Stazi M; Bouter C; Wirths O; Vogelgsang J; Wiltfang J
Alzheimers Res Ther; 2018 Dec; 10(1):121. PubMed ID: 30526652
[TBL] [Abstract][Full Text] [Related]
3. Rolling circle amplification integrated with suspension bead array for ultrasensitive multiplex immunodetection of tumor markers.
Gao M; Lian H; Yu L; Gong M; Ma L; Zhou Y; Yu M; Yan X
Anal Chim Acta; 2019 Feb; 1048():75-84. PubMed ID: 30598160
[TBL] [Abstract][Full Text] [Related]
4. Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment.
Blennow K; De Meyer G; Hansson O; Minthon L; Wallin A; Zetterberg H; Lewczuk P; Vanderstichele H; Vanmechelen E; Kornhuber J; Wiltfang J; ; Heuser I; Maier W; Luckhaus C; Rüther E; Hüll M; Jahn H; Gertz HJ; Frölich L; Hampel H; Pernetzki R
J Nutr Health Aging; 2009 Mar; 13(3):205-8. PubMed ID: 19262954
[TBL] [Abstract][Full Text] [Related]
5. Multiplex immunoassay measurement of amyloid-β
Vogelgsang J; Shahpasand-Kroner H; Vogelgsang R; Streit F; Vukovich R; Wiltfang J
Exp Brain Res; 2018 May; 236(5):1241-1250. PubMed ID: 29480353
[TBL] [Abstract][Full Text] [Related]
6. Immunodetection and counting of circulating tumor cells (HepG2) by combining gold nanoparticle labeling, rolling circle amplification and ICP-MS detection of gold.
Li X; Chen B; He M; Hu B
Mikrochim Acta; 2019 May; 186(6):344. PubMed ID: 31076917
[TBL] [Abstract][Full Text] [Related]
7. Fully automated chemiluminescence enzyme immunoassays showing high correlation with immunoprecipitation mass spectrometry assays for β-amyloid (1-40) and (1-42) in plasma samples.
Yamashita K; Watanabe S; Ishiki K; Miura M; Irino Y; Kubo T; Matsui J; Hagino K; Iwanaga S; Yoshida T
Biochem Biophys Res Commun; 2021 Oct; 576():22-26. PubMed ID: 34478915
[TBL] [Abstract][Full Text] [Related]
8. Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in Plasma.
Pérez-Grijalba V; Fandos N; Canudas J; Insua D; Casabona D; Lacosta AM; Montañés M; Pesini P; Sarasa M
J Alzheimers Dis; 2016 Sep; 54(2):751-62. PubMed ID: 27567833
[TBL] [Abstract][Full Text] [Related]
9. A Sensitive and Cost-Effective Chemiluminescence ELISA for Measurement of Amyloid-β 1-42 Peptide in Human Plasma.
Mehta PD; Patrick BA; Miller DL; Coyle PK; Wisniewski T
J Alzheimers Dis; 2020; 78(3):1237-1244. PubMed ID: 33252086
[TBL] [Abstract][Full Text] [Related]
10. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
[TBL] [Abstract][Full Text] [Related]
11. Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
Kim HJ; Park KW; Kim TE; Im JY; Shin HS; Kim S; Lee DH; Ye BS; Kim JH; Kim EJ; Park KH; Han HJ; Jeong JH; Choi SH; Park SA
J Alzheimers Dis; 2015; 48(4):1043-50. PubMed ID: 26444752
[TBL] [Abstract][Full Text] [Related]
12. Validation of a Chemiluminescence Immunoassay for Measuring Amyloid-β in Human Blood Plasma.
Vogelgsang J; Wiltfang J; Klafki HW
Methods Mol Biol; 2018; 1750():111-124. PubMed ID: 29512068
[TBL] [Abstract][Full Text] [Related]
13. Bio-bar-code-based photoelectrochemical immunoassay for sensitive detection of prostate-specific antigen using rolling circle amplification and enzymatic biocatalytic precipitation.
Zhang K; Lv S; Lin Z; Li M; Tang D
Biosens Bioelectron; 2018 Mar; 101():159-166. PubMed ID: 29065341
[TBL] [Abstract][Full Text] [Related]
14. DNA encapsulating liposome based rolling circle amplification immunoassay as a versatile platform for ultrasensitive detection of protein.
Ou LJ; Liu SJ; Chu X; Shen GL; Yu RQ
Anal Chem; 2009 Dec; 81(23):9664-73. PubMed ID: 19877619
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of AD markers using naked eyes: point-of-care testing with paper-based lateral flow immunoassay.
Zhang L; Du X; Su Y; Niu S; Li Y; Liang X; Luo H
J Nanobiotechnology; 2021 Nov; 19(1):366. PubMed ID: 34789291
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans : CSF AD biomarkers measured by Lumipulse in Koreans.
Moon S; Kim S; Mankhong S; Choi SH; Vandijck M; Kostanjevecki V; Jeong JH; Yoon SJ; Park KW; Kim EJ; Yoon B; Kim HJ; Jang JW; Hong JY; Park DH; Shaw LM; Kang JH
Alzheimers Res Ther; 2021 Jan; 13(1):22. PubMed ID: 33436035
[TBL] [Abstract][Full Text] [Related]
17. A dual-signal amplification strategy based on rolling circle amplification and APE1-assisted amplification for highly sensitive and specific miRNA analysis for early diagnosis of alzheimer's disease.
Xie J; Chen J; Zhang Y; Li C; Liu P; Duan WJ; Chen JX; Chen J; Dai Z; Li M
Talanta; 2024 May; 272():125747. PubMed ID: 38364557
[TBL] [Abstract][Full Text] [Related]
18. Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.
Chatterjee P; Elmi M; Goozee K; Shah T; Sohrabi HR; Dias CB; Pedrini S; Shen K; Asih PR; Dave P; Taddei K; Vanderstichele H; Zetterberg H; Blennow K; Martins RN
J Alzheimers Dis; 2019; 71(3):775-783. PubMed ID: 31424403
[TBL] [Abstract][Full Text] [Related]
19. Rolling circle amplification immunoassay combined with gold nanoparticle aggregates for colorimetric detection of protein.
Wang P; Jin B; Xing Y; Cheng Z; Ge Y; Zhang H; Hu B; Mao H; Jin Q; Zhao J
J Nanosci Nanotechnol; 2014 Aug; 14(8):5662-8. PubMed ID: 25935986
[TBL] [Abstract][Full Text] [Related]
20. A label-free reusable aptasensor for Alzheimer's disease.
Ren HX; Zhong Q; Miao YB; Wen XW; Wu GY; Wang HL; Zhang Y
Mikrochim Acta; 2020 Aug; 187(9):515. PubMed ID: 32839875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
